These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23184910)

  • 1. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.
    Cui T; Tsolakis AV; Li SC; Cunningham JL; Lind T; Öberg K; Giandomenico V
    Eur J Endocrinol; 2013 Feb; 168(2):253-61. PubMed ID: 23184910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids.
    Giandomenico V; Cui T; Grimelius L; Öberg K; Pelosi G; Tsolakis AV
    J Mol Endocrinol; 2013 Dec; 51(3):277-86. PubMed ID: 23969981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas.
    Leja J; Essaghir A; Essand M; Wester K; Oberg K; Tötterman TH; Lloyd R; Vasmatzis G; Demoulin JB; Giandomenico V
    Mod Pathol; 2009 Feb; 22(2):261-72. PubMed ID: 18953328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
    Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
    Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype.
    Almobarak B; Amlani V; Inge L; Hofving T; Muth A; Nilsson O; Johansson M; Arvidsson Y; Elias E
    BMC Cancer; 2023 Mar; 23(1):267. PubMed ID: 36959559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
    Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
    Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilin-2 contributes to tumor progression in preclinical models of small intestinal neuroendocrine tumors.
    Bollard J; Patte C; Radkova K; Massoma P; Chardon L; Valantin J; Gadot N; Goddard I; Vercherat C; Hervieu V; Gouysse G; Poncet G; Scoazec JY; Walter T; Roche C
    J Pathol; 2019 Nov; 249(3):343-355. PubMed ID: 31257576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
    Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
    Iijima M; Yokobori T; Mogi A; Shimizu K; Yajima T; Kosaka T; Ohtaki Y; Obayashi K; Nakazawa S; Gombodorj N; Tsukagoshi M; Shirabe K; Kuwano H
    Ann Surg Oncol; 2019 Jun; 26(6):1744-1750. PubMed ID: 30924018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line.
    Pronin A; Slepak V
    J Biol Chem; 2021; 296():100475. PubMed ID: 33640452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
    Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
    PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
    Li SC; Essaghir A; Martijn C; Lloyd RV; Demoulin JB; Oberg K; Giandomenico V
    Mod Pathol; 2013 May; 26(5):685-96. PubMed ID: 23328977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia.
    Lawrence B; Kenney B; Svejda B; Schimmack S; Alaimo D; Barbieri A; Jedrych J; Kidd M; Modlin I
    BMC Res Notes; 2012 Jun; 5():318. PubMed ID: 22720672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the stomach: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA.
    Ding J; Sun P; Cai XY; Fei SH; Wu J; Qi YK; Liu ZB; Yuan L; He YJ; Song H; Chen WX
    Int J Clin Exp Pathol; 2014; 7(12):9076-80. PubMed ID: 25674291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma.
    Ishikubo T; Akagi K; Kurosumi M; Yamaguchi K; Fujimoto T; Sakamoto H; Tanaka Y; Ochiai A
    Jpn J Clin Oncol; 2006 Aug; 36(8):494-8. PubMed ID: 16844734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.
    Vranic S; Palazzo J; Sanati S; Florento E; Contreras E; Xiu J; Swensen J; Gatalica Z
    Clin Breast Cancer; 2019 Apr; 19(2):131-136. PubMed ID: 30268765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.